Published in Oncotarget on May 17, 2016
Elevated Mitochondrial DNA Copy Number in Peripheral Blood and Tissue Predict the Opposite Outcome of Cancer: A Meta-Analysis. Sci Rep (2016) 0.75
MtDNA As a Cancer Marker: A Finally Closed Chapter? Curr Genomics (2017) 0.75
Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer. Br J Cancer (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res (2010) 10.90
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science (1989) 9.71
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res (2008) 6.95
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med (2006) 6.04
Mitochondria and cancer. Nat Rev Cancer (2012) 4.81
Subtypes of breast cancer show preferential site of relapse. Cancer Res (2008) 4.38
Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res (1990) 3.13
Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab (2015) 3.06
Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol (2006) 2.68
mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet (1991) 2.53
Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucleic Acids Res (2003) 2.02
Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J Cell Sci (2007) 1.98
Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB Life (2007) 1.92
An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology (1999) 1.92
Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer (2006) 1.77
Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer (2007) 1.75
Tumor-specific changes in mtDNA content in human cancer. Int J Cancer (2005) 1.70
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. J Clin Oncol (2008) 1.47
Simultaneous detection and quantification of mitochondrial DNA deletion(s), depletion, and over-replication in patients with mitochondrial disease. J Mol Diagn (2005) 1.43
Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers. Life Sci (2011) 1.42
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. Elife (2014) 1.39
Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics (2013) 1.36
Copy number alterations that predict metastatic capability of human breast cancer. Cancer Res (2009) 1.33
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res (2013) 1.29
Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene (2005) 1.23
Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2. Cell Death Differ (2008) 1.22
Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. Cancer Res (2011) 1.20
Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ (1997) 1.19
Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol Ther (2008) 1.15
The regulation of mitochondrial DNA copy number in glioblastoma cells. Cell Death Differ (2013) 1.09
Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res (1994) 1.09
Mitochondrial DNA copy number is regulated by cellular proliferation: a role for Ras and p66(Shc). Biochim Biophys Acta (2006) 1.08
Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. J Clin Virol (2001) 1.07
Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues. BMC Genomics (2009) 1.05
Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer. J Cancer Res Clin Oncol (2009) 1.03
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer. Breast Cancer Res Treat (2013) 1.02
The awakening of an advanced malignant cancer: an insult to the mitochondrial genome. Biochim Biophys Acta (2011) 1.02
Progressive tumor features accompany epithelial-mesenchymal transition induced in mitochondrial DNA-depleted cells. Cancer Sci (2008) 1.01
Depletion of mitochondrial DNA by ethidium bromide treatment inhibits the proliferation and tumorigenesis of T47D human breast cancer cells. Toxicol Lett (2007) 1.00
Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells. Oncogene (2013) 0.98
Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations. Hum Mol Genet (2010) 0.95
Induction of acquired resistance to antiestrogen by reversible mitochondrial DNA depletion in breast cancer cell line. Int J Cancer (2008) 0.95
Mitochondrial DNA content as a potential marker to predict response to anthracycline in breast cancer patients. Breast J (2010) 0.93
mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft. BMC Genomics (2008) 0.91
Infection with HIV-1 induces a decrease in mtDNA. J Infect Dis (2005) 0.91
Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells. Eur J Cancer Prev (2009) 0.89
Mitochondrial DNA content varies with pathological characteristics of breast cancer. J Oncol (2011) 0.88
Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates. Carcinogenesis (2014) 0.87
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas. BMC Cancer (2015) 0.80